Landstinget Kronoberg, Sweden Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
1995
NCT01109927
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1995

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1